<DOC>
	<DOCNO>NCT02096731</DOCNO>
	<brief_summary>Background : Recent observational study report possible arrhythmogenic effect long-acting beta-agonists ( LABA ) , long-acting anticholinergic tiotropium associate cardiovascular cerebrovascular event . Finally , pneumonia object recent signal trial LABAs submit marketing approval . Aim : To assess potential cardio-pulmonary risk arise concurrent use two long-acting bronchodilator well monotherapy use long-acting bronchodilator . Methods : A series population-based cohort study , use cohort nest case-control analysis conduct use data United Kingdom 's Clinical Practice Research Datalink ( CPRD ) . The base cohort consist new user long-acting bronchodilator Jan 2002 Aug 2012 , age &gt; = 55 chronic obstructive pulmonary disease ( COPD ) least two year baseline medical history information . The high-dimensional propensity score technique use match new user long-acting bronchodilator new user two bronchodilator comparable subject base cohort , one-year follow-up outcome acute myocardial infarction , stroke , heart failure , arrhythmia community acquire pneumonia . Data analyse use time-dependent Cox proportional hazard regression model conditional logistic regression model .</brief_summary>
	<brief_title>Combined Bronchodilators Chronic Obstructive Pulmonary Disease Risk Adverse Cardio-pulmonary Events</brief_title>
	<detailed_description>Purpose :</detailed_description>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Chronic Disease</mesh_term>
	<mesh_term>Bronchodilator Agents</mesh_term>
	<criteria>Inclusion criterion : New user longacting bronchodilator , either LABA tiotropium , January 2002 August 2012 Age &gt; = 55 year Exclusion criterion : Use LABA tiotropium two year prior cohort entry</criteria>
	<gender>All</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>